Madison Muller
Health Reporter at Bloomberg News
Health reporter @business | Email: [email protected] | Chicago ➵ NYC | @medillschool always
Articles
-
1 week ago |
bloomberglinea.com | John Tozzi |Madison Muller |Stephanie Lai
Bloomberg — El presidente Donald Trump quiere que el Congreso cambie una política que da a ciertos medicamentos una protección más prolongada frente a las negociaciones de precios en Medicare, un arreglo que podría resolver una de las principales quejas de la industria farmacéutica con la ley de la era Biden.
-
1 week ago |
southfloridareporter.com | John Tozzi |Madison Muller |Stephanie Lai
President Donald Trump wants Congress to change a policy that gives certain drugs longer protection from drug price negotiations in Medicare, a fix that could address one of the drug industry's top complaints with the Biden-era law. Trump directed his health secretary to work with lawmakers to end the differential treatment for small molecule drugs, typically pills, that face Medicare price negotiations sooner that more complex biologic medications.
-
1 week ago |
thebrunswicknews.com | John Tozzi |Madison Muller |Stephanie Lai
President Donald Trump wants Congress to change a policy that gives certain drugs longer protection from drug price negotiations in Medicare, a fix that could address one of the drug industry's top complaints with the Biden-era law. Trump directed his health secretary to work with lawmakers to end the differential treatment for small molecule drugs, typically pills, that face Medicare price negotiations sooner than more complex biologic medications.
-
1 week ago |
gazettextra.com | John Tozzi |Madison Muller |Stephanie Lai
President Donald Trump wants Congress to change a policy that gives certain drugs longer protection from drug price negotiations in Medicare, a fix that could address one of the drug industry's top complaints with the Biden-era law. Trump directed his health secretary to work with lawmakers to end the differential treatment for small molecule drugs, typically pills, that face Medicare price negotiations sooner than more complex biologic medications. Copyright 2025 Tribune Content Agency.
-
1 week ago |
keenesentinel.com | John Tozzi |Madison Muller |Stephanie Lai
President Donald Trump wants Congress to change a policy that gives certain drugs longer protection from drug price negotiations in Medicare, a fix that could address one of the drug industry’s top complaints with the Biden-era law. Trump directed his health secretary to work with lawmakers to end the differential treatment for small molecule drugs, typically pills, that face Medicare price negotiations sooner than more complex biologic medications.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 5K
- Tweets
- 12K
- DMs Open
- Yes
At @SecKennedy’s event in Phoenix, I spoke with Sam Malinski, a mom of two from Sedona: “I think it’s the start to cleaning up our food supply,” she told me. “I’m grateful that Secretary Kennedy and our local legislators are aware and doing something about it.”
HHS Secretary Robert F. Kennedy Jr. joined lawmakers in Arizona on Tuesday to celebrate the passage of two bills targeting causes he’s championed in his Make America Healthy Again agenda. Live from Phoenix for @business : https://t.co/SIMBLWVMVt?
Breaking: The Trump administration decided it won’t allow Medicare to pay for obesity drugs, a move that would’ve expanded access to millions of older adults. From me and @jtozz https://t.co/tmVmrVDYIJ
RT @Alexander_Tin: Today @SecKennedy said he'll undo some layoffs in @HHSGov "was always the plan. Part of the @DOGE, we talked about this…